Zylo Therapeutics (fka )

[Ubertino]

https://www.panaceanano.com/

Management

Dr. Youssry Botros is a co-founder and the Chief Executive Officer of PanaceaNano Inc. Prior to founding PanaceaNano Inc, he spent 16 years at Intel Corporation where he focused on Nano-scale material systems and their emerging applications, such as beyond CMOS electronics, ultra-low power information processing, bio-inspired computing, energy generation, storage, and harvesting, Organic Photovoltaics, Organic Functional Systems, Silicon Photonics, low energy displays, and wearables. He founded and managed many Intel collaborations in these areas. He founded and chaired the SEMI International Process Control Systems Task Force (PCS-TF) with tens of global companies semiconductor participating. PCS-TF defined the PCS SEMI Standards (known as E133). Youssry published more than 60 papers in top journals and magazines (including Science and Nature), more than 200 conference papers, 4 book chapters, 3 patents and made numerous presentations to different industrial and academic forums. Youssry got his Ph.D. from the University of Michigan, Ann Arbor in 1998 and his M.Sc. and B.Sc. from Alexandria University in 1993 and 1990, respectively.

Sir Fraser Stoddart is a co-founder and the Chief Technology Officer of PanaceaNano Inc. He is one of the few chemists of the past quarter of a century to have created a new field of organic chemistry — namely, one in which the mechanical bond is a pre-eminent feature of molecular compounds. He has pioneered the development of the use of molecular recognition and self-assembly processes in template-directed protocols for the syntheses of two-state mechanically interlocked compounds (bistable catenanes and rotaxanes) that have been employed as molecular switches and as motor-molecules in the fabrication of nanoelectronic devices and NanoElectroMechanical Systems (NEMS).

His work has been recognized by many awards, including the Nobel Prize in Chemistry (2016), the American Chemical Society’s Cope Award (2008), the Royal Society's Davy Medal (2008), the King Faisal International Prize in Science (2007), the Tetrahedron Prize for Creativity in Organic Chemistry (2007), the Albert Einstein World Award of Science (2007), the Foresight Nanotech Institute Feynman Prize in Nanotechnology (Experimental) (2007), the Nagoya Gold Medal in Organic Chemistry (2004), the American Chemical Society’s Cope Scholar Award (1999), the International Izatt-Christensen Award in Macrocyclic Chemistry (1993), and the Carbohydrate Chemistry Award of The Chemical Society (1978). He is currently on the international advisory boards of numerous journals, including Chemistry World, ChemPlusChem, Macromolecular Rapid Communications and Organic Letters. He is editor-in-chief of Applied Nanoscience. He is a Fellow of the Royal Society (1994), the German Academy (Leopoldina) of Natural Sciences (1999), the American Association for the Advancement of Science (2005), and the Science Division of the Royal Netherlands Academy of Arts and Sciences (2006). He is a member of the American Academy of Arts and Sciences (2012) and the National Academy of Sciences (2014). He is an honorary fellow of the Royal Society of Edinburgh (2008) and the Royal Society of Chemistry (2011). He was appointed by Her Majesty Queen Elizabeth II as a Knight Bachelor in her 2007 New Year’s Honours List for his services to chemistry and molecular nanotechnology. In 2010 he was the recipient of a Royal Medal, granted by Her Majesty Queen Elizabeth II, and presented by Prince Philip, Duke of Edinburgh, at the Royal Society of Edinburgh.

Samer Taha, Ph.D.
Vice President of Business Development
Grey LinkedIn Icon
Grey Twitter Icon
Dr. Samer Taha is the Vice President of Business Development at PanaceaNano Inc. He oversees expanding PanaceaNano’s business alliances and commercial opportunities. Dr. Samer is also founder and CEO of Waseela for Integrated ICT Solutions (www.waseela.com), a regional master system integrator specialized in advanced wireless and ICT solutions that has deployed and integrated thousands of networking and ICT systems since its establishment. He is also a board member at Dar Al Hai, www.daralhai.com, a regional trade and investment group with annual turnover of more than USD 1.2 Billion in 2016. Between 1999 and 2002, Samer was a member of the CICTR Lab (http://cictr.ee.psu.edu) at the Pennsylvania State University where he got his Ph.D. in Electrical Engineering in 2002. Then he joined Intel Corporation in 2002 where he worked as a senior research engineer and R&D manager for 5 years in next-generation silicon wafer processing technologies and embedded wireless systems, during which he published 4 patents. He later founded Waseela in 2007 and focused more on the business development and commercial consultations services, he participated in numerous industry conferences as a speaker and industry leader. Samer got his B.Sc. in Electrical Engineering from the Jordan University of Science & Technology in 1998.

Benjie Limketkai, Ph.D.
Director of Platform Development
Benjie Limketkai is the director of platform development for PanaceaNano Inc. He leads the execution of technology strategy and overseas platform development and integration of the various technologies and intellectual property created. He has over 10 years of industry experience in nanotechnology. Prior to joining PanaceaNano Inc, he worked at Intel Corporation in the process technology development for Intel's 14nm and 7nm nodes. He was the lead research scientist for organic nanotechnology research at Intel Labs and engaged in collaboration with multiple universities. He received his Ph.D. in Electrical Engineering from the Massachusetts Institute of Technology and his B.S. from the California Institute of Technology.

https://www.panaceanano.com/management